Market

FDA Once Again Finding Antibiotics in Indian Shrimp

Photo of author

By Milthon Lujan

USA.- The U.S. Food and Drug Administration (FDA) published data this morning reporting that there were 56 total seafood entry line refusals in March, of which 3 were of shrimp for reasons related to banned antibiotics (5.4%).

Anuncios

The FDA has now reported a total of fourteen refusals of shrimp entry lines for reasons related to banned antibiotics through the first four months of 2020.

The three shrimp entry lines refused in April were for shipments from three different companies in two separate countries:

– Ram’s Assorted Cold Storage Limited (India), a company that is currently listed on Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) as of October 10, 2019, had one entry line refused for shrimp contaminated with nitrofurans and veterinary drug residues by the Division of Northern Border Imports on April 2, 2020;

– Neeli Aqua Private Limited (India), a company that is currently listed on Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) as of April 24, 2020, had one entry line refused for shrimp contaminated with nitrofurans and veterinary drug residues by the Division of West Coast Imports on April 7, 2020; and

Anuncios

– Lee Fung Marine Products Trading (Hong Kong), a company that is not currently listed on Import Alert 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”), Import Alert 16-127 (“Detention Without Physical Examination of Crustaceans Due to Chloramphenicol”), or Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”), had one entry line refused for shrimp contaminated with veterinary drug residues and an unsafe additive by the Division of West Coast Imports on April 24, 2020.

See also  Senate Votes 87-11 to Increase Funding for FDA Inspections of Foreign Seafood Facilities and Imported Seafood

In addition, the FDA reported refusing five additional entry lines of shrimp after detecting the presence of salmonella. Three of these entry lines were of shrimp from India, while one was from the Philippines, and one was from Bangladesh.

Source: Southern Shrimp Alliance

Leave a Comment